Susquehanna International Group
BBNX

Susquehanna International Group’s Beta Bionics BBNX Stock Holding History

Susquehanna International Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135K Sell
13,428
-1,405
-9% -$20.8K ﹤0.01% 12118
2025
Q4 		$452K Buy
+14,833
New +$396K ﹤0.01% 9031
2025
Q3 		– Sell
-15,516
Closed -$226K – 14276
2025
Q2 		$226K Sell
15,516
-388
-2% -$5.49K ﹤0.01% 10956
2025
Q1 		$195K Buy
+15,904
New +$297K ﹤0.01% 10957

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's BBNX Position: Q1 2026 in Review

Susquehanna International Group reduced its Beta Bionics (BBNX) stake by 9.5% in Q1 2026, selling an estimated $20.8K and leaving 13,428 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #12118.

Susquehanna International Group first reported a position in BBNX in Q1 2025 and has held it in 4 quarters since. The position peaked at $452K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Susquehanna International Group held 13,428 shares of Beta Bionics worth $135K as of Q1 2026.
  • Susquehanna International Group sold 1,405 Beta Bionics shares in Q1 2026, an estimated $20.8K.
  • Beta Bionics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12118 holding.
  • Susquehanna International Group first reported a position in Beta Bionics in Q1 2025 and has held it in 4 quarters since.
  • Susquehanna International Group's Beta Bionics position peaked at $452K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.